| Bioactivity | Apoptosis inducer 35 (Compound 6) is a multi-targeted inhibitor, that reduces the expressions of EGFR, AKT, ERK and P38-MAPKα. Apoptosis inducer 35 inhibits the proliferation of cancer cell A549 and Jurkat, arrests the cell cycle at S phase, and induces apoptosis[1]. |
| Formula | C23H21ClN8O2S2 |
| Molar Mass | 541.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Boraei ATA, et al., Synthesis of new functionalized bioactive S-substituted indolyl-triazoles as cytotoxic and apoptotic agents through multi-targeted kinase inhibition. Bioorg Chem. 2025 Jan 10;156:108154. |
Apoptosis inducer 35
CAS: F: C23H21ClN8O2S2 W: 541.05
Apoptosis inducer 35 (Compound 6) is a multi-targeted inhibitor, that reduces the expressions of EGFR, AKT, ERK and P38-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.